IABP-SHOCK II
Intra-Aortic Balloon Pump in Cardiogenic Shock
Patient / Population Intervention / Exposure Comparison Outcome
In 600 patients with MI-related cardiogenic shock undergoing revascularisation, intra-aortic balloon counterpulsation did not reduce 30-day mortality versus no IABP.
N
600
Design
Multicentre RCT, Germany
Endpoint
30-day all-cause mortality
Relevance
1
Result39.7% vs 41.3% (RR 0.96; p=0.69). Persistent null at 1, 6 and 12 y.
Thiele H, et al. N Engl J Med. 2012;367(14):1287-1296. 10.1056/NEJMoa1208410
Discussion & critique
Retired routine IABP; guidelines downgraded to Class IIIa.